Table S5 from Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Year: 2025
Type: other
Abstract: Table S5 summarizes exposure to the study drugs in Cohort C.
Authors: Matthew D. Galsky, Karen A. Autio, Christopher R. Cabanski, Kristopher Wentzel, Julie N. Graff, Terence W. Friedlander, Timothy R. Howes, Kristin M. Shotts, Julie Densmore, Marko Spasic, Diane M. Da Silva, Richard O. Chen, Jennifer Lata, Jeffrey Skolnik, Tibor Keler, Michael J. Yellin, Theresa M. LaVallee, Justin Fairchild, Silvia Boffo, Jill O’Donnell-Tormey, Ute Dugan, Nina Bhardwaj, Sumit K. Subudhi, Lawrence Fong
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410339446